By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087



Company News
As Stock Recovers, Duke University Spinout Aerie (AERI) Expands R&D Into Research Triangle Park 7/17/2015 6:17:43 AM
Aerie (AERI) To Present At The Cantor Fitzgerald 2015 Healthcare Conference 7/1/2015 11:04:26 AM
Aerie (AERI) Elects Julie Mchugh And Michael M. du Toit To The Company’s Board Of Directors 6/29/2015 10:30:50 AM
Aerie (AERI) Receives Positive Feedback From FDA 6/16/2015 11:59:49 AM
Aerie (AERI) To Participate In Two Investor Conferences In June 5/27/2015 11:38:33 AM
Aerie (AERI) Elects Richard Croarkin To The Company’s Board Of Directors 5/7/2015 12:59:23 PM
Aerie (AERI) To Announce First Quarter 2015 Financial Results And Host Conference Call On Thursday, May 7, 2015 4/29/2015 12:10:06 PM
Aerie (AERI) Reports Initial Rhopressa Phase III Efficacy Results 4/24/2015 5:49:59 AM
Aerie (AERI) Freefalls Aftermarket as Rhopressa Fails Phase III Study 4/23/2015 8:29:33 PM
Aerie Pharmaceuticals, Inc. (AERI) To Present At The 14th Annual Needham Healthcare Conference 4/8/2015 9:59:57 AM